Loading organizations...
Loading organizations...
Biopharmaceutical company developing treatments for ophthalmic conditions.
Tarsus Pharmaceuticals has raised $60.0M across 1 funding round.
Tarsus Pharmaceuticals has raised $60.0M in total across 1 funding round.
Tarsus Pharmaceuticals has raised $60.0M in total across 1 funding round.
Tarsus Pharmaceuticals's investors include Chen Yu, Aperture Venture Partners, Flying L Partners, Frazier Healthcare Partners, Horowitz Group, Visionary Ventures.
Tarsus Pharmaceuticals has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series B in January 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 8, 2020 | $60.0M Series B | Chen Yu | Aperture Venture Partners, Flying L Partners, Frazier Healthcare Partners, Horowitz Group, Visionary Ventures |